Shaikh, Sana
Matzumura Umemoto, Gonzalo
Vijayan, Anitha
2020-08-19T14:06:14Z
2020-08-19T14:06:14Z
2020
1548-5595
https://doi.org/10.1053/j.ackd.2020.08.002
http://hdl.handle.net/20.500.12010/11956
Acute kidney injury is a common complication in hospitalized patients with COVID-19. Similar to
AKI associated with other conditions such as sepsis and cardiac surgery, morbidity and
mortality are much higher in patients with COVID-19 who develop AKI, especially in the
intensive care unit. Management of COVID-19 associated AKI with kidney replacement therapy
(KRT) should follow existing recommendations regarding modality, dose, and timing of initiation.
However, patients with COVID-19 are very hypercoagulable and close vigilance to
anticoagulation strategies is necessary to prevent circuit clotting. During situations of acute
surge, where demand for KRT outweighs supplies, conservative measures have to be
implemented to safely delay KRT. A collaborative effort and careful planning is needed to
conserve dialysis supplies, to ensure that treatment can be safely delivered to every patient who
will benefit for KRT.
38 páginas
image/jepg
Advances in Chronic Kidney Disease
reponame:Expeditio Repositorio Institucional UJTL
instname:Universidad de Bogotá Jorge Tadeo Lozano
COVID-19
Kidney Injury
Management of acute kidney injury in COVID-19
Artículo
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
info:eu-repo/semantics/embargoedAccess
info:eu-repo/semantics/acceptedVersion
Acceso restringido
https://doi.org/10.1053/j.ackd.2020.08.002